Royalty Pharma $500 Million Royalty Agreement with Ferring Pharmaceuticals

Fenwick & West represented Royalty Pharma, and Orrick Herrington & Sutcliffe represented Ferring Pharmaceuticals in the deal.Royalty Pharma plc (Nasdaq: RPRX) and Ferring Pharmaceuticals announced that…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here